Product Description
an Anti-IL-21 Monoclonal Antibody for Rheumatoid Arthritis (Sourced from: https://acrabstracts.org/abstract/safety-and-tolerability-of-nnc0114%C2%AD0006-an-anti-il-21-monoclonal-antibody-at-multiple-s-c-dose-levels-in-patients-with-rheumatoid-arthritis/)
Mechanisms of Action: IL21 Inhibitor
Novel Mechanism: Yes
Modality: Antibody
Route of Administration: Intravenous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Novo Nordisk
Company Location: BAGSVAERD DENMARK G7 00000
Company CEO: Lars Fruergaard Jorgensen
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Type 1 Diabetes|Crohn Disease|Inflammation|Arthritis, Rheumatoid
Phase 1: Lupus Erythematosus, Systemic|Inflammation|Arthritis, Rheumatoid
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01689025 |
NN8828-4002 | P1 |
Terminated |
Inflammation|Lupus Erythematosus, Systemic |
2014-02-01 |
2019-03-19 |
Treatments |
|
NCT01565408 |
NN8828-3841 | P1 |
Completed |
Arthritis, Rheumatoid|Inflammation |
2013-10-01 |
2019-03-19 |
Treatments |
|
2014-001215-39 |
2014-001215-39 | P2 |
Completed |
Type 1 Diabetes |
2019-02-27 |
72% |
2022-03-13 |
Treatments |
NCT02443155 |
NN9828-4150 | P2 |
Completed |
Type 1 Diabetes |
2018-08-31 |
72% |
2019-03-20 |
|
2012-002432-93 |
2012-002432-93 | P2 |
Completed |
Crohn Disease |
2014-12-19 |
2022-03-13 |
Treatments |
|
NCT01751152 |
NN8828-4004 | P2 |
Completed |
Crohn Disease|Inflammation |
2014-12-01 |
2019-03-19 |
Treatments |
|
NCT01647451 |
NN8828-3842 | P2 |
Completed |
Arthritis, Rheumatoid|Inflammation |
2013-08-01 |
2019-03-19 |
Treatments |
|
2011-005376-42 |
2011-005376-42 | P2 |
Completed |
Arthritis, Rheumatoid |
2013-07-13 |
2022-03-13 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|